SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-062915
Filing Date
2023-11-13
Accepted
2023-11-13 16:05:42
Documents
62
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q ktra-20230930.htm   iXBRL 10-Q 1668165
2 EX-31.1 ktra-ex31_1.htm EX-31.1 18452
3 EX-31.2 ktra-ex31_2.htm EX-31.2 18240
4 EX-32.1 ktra-ex32_1.htm EX-32.1 11494
  Complete submission text file 0000950170-23-062915.txt   7252342

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ktra-20230930.xsd EX-101.SCH 72848
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ktra-20230930_def.xml EX-101.DEF 302110
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ktra-20230930_cal.xml EX-101.CAL 22541
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ktra-20230930_pre.xml EX-101.PRE 406192
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ktra-20230930_lab.xml EX-101.LAB 493370
56 EXTRACTED XBRL INSTANCE DOCUMENT ktra-20230930_htm.xml XML 1195017
Mailing Address 9920 PACIFIC HEIGHTS BLVD, SUITE 150 SAN DIEGO CA 92121
Business Address 9920 PACIFIC HEIGHTS BLVD, SUITE 150 SAN DIEGO CA 92121 (858) 350-4364
Kintara Therapeutics, Inc. (Filer) CIK: 0001498382 (see all company filings)

IRS No.: 990360497 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-37823 | Film No.: 231398598
SIC: 2834 Pharmaceutical Preparations